Manisha Balwani, MD, MS

Co-director, Comprehensive Gaucher Disease Treatment Denter; Co-director, Comprehensive Porphyria Diagnostic and Treatment Center; Assistant Professor, Department of Genetics and Genomic Sciences and Department of Medicine, Mount Sinai School of Medicine, New York City.

Dr. Balwani specializes in Clinical Genetics with a focus on Gaucher Disease and Porphyria. She was appointed Co-Director of Mount Sinai’s Comprehensive Gaucher Disease Treatment Center, the single largest clinic in the world devoted to the diagnosis and treatment of Gaucher disease, in 2006. In 2007, she was appointed Co-Director of the Comprehensive Porphyria Diagnostic and Treatment Center.

Dr. Balwani is currently involved in at least ten studies exploring treatment for inherited metabolic disorders, such as Gaucher and Porphyria, including development of a Gaucher Registry. Dr. Balwani has authored or co-authored numerous articles for scientific journals and presented research at dozens of medical conferences. She’s also authored or co-authored a number of book chapters and is often invited to present at medical centers around the country.

Dr. Balwani has been an Attending Physician at Mount Sinai’s Department of Medicine and in the Department of Pediatrics since 2006. That same year, she was appointed an Assistant Professor in the Department of Genetics and Genomic Sciences and in the Department of Medicine.

Dr. Balwani received her M.D. from T.N. Medical College in Bombay, India in 1997 and earned an M.S. in Human Genetics in June 1999 from the University of Pittsburgh, Pennsylvania.

She did her Residency in Internal Medicine at New York’s North Shore University Hospital from July 2000-June 2003 and joined Mount Sinai School of Medicine with a fellowship in Clinical Genetics from July 2003-June 2005, followed by a Fellowship in Clinical Biochemical Genetics from September 2005-Aug 2006.

Dr. Balwani is a Diplomate of the American Board of Internal Medicine and a Diplomate of the American Board of Medical Genetics.

She is an Advisory Board Member for the North American International Collaborative Gaucher Group (ICGG) and a “Protect our Future” physician for the American Porphyria Foundation.

A recipient of the NORD/ Roscoe Brady Lysosomal Diseases Fellowship Award in 2006, Dr. Balwani received the Genetic Disease Foundation ‘Clinical Excellence Award’ in 2009.

More about Dr. Balwani on the Mount Sinai Medical Center website.